Evaluation of the application of the ACCF/ASE appropriateness criteria for transesophageal echocardiography in an academic medical center.

BACKGROUND: The aim of this study was to prospectively evaluate the clinical application of the recently published American College of Cardiology Foundation and American Society of Echocardiography appropriateness criteria (AC) for transesophageal echocardiographic (TEE) imaging at a single-center university hospital. METHODS: As outlined in the AC, TEE studies were divided into those performed subsequent to transthoracic echocardiographic imaging (adjunctive TEE studies) and those that were the initial echocardiographic studies for the indications being evaluated (initial TEE studies). Each study was categorized as appropriate, uncertain, or inappropriate, according to the relevant section of the AC, and the study's impact on patient management was determined. RESULTS: Of the 405 studies enrolled, 27% were adjunctive and 73% were initial. Ninety-one percent of TEE studies could be classified by the AC. Overall, 97% of the studies were appropriate, 1% were inappropriate, and 2% were uncertain. Patient management was affected by 94% of appropriate studies but by only 50% of uncertain or inappropriate studies. CONCLUSIONS: The AC for TEE imaging can be feasibly applied and encompass the majority of the clinical practice of transesophageal echocardiography in an academic setting.

Predictors of long-term mortality in patients with ischemic stroke referred for transesophageal echocardiography.

BACKGROUND AND PURPOSE: Findings on transesophageal echocardiography (TEE) after ischemic stroke predict recurrent embolic events and prompt therapy; however, the additive predictive power of TEE findings on long-term mortality is unknown. Our goal was to study the impact of TEE findings on all cause mortality in ischemic stroke patients referred for TEE. METHODS: We reviewed 245 consecutive patients who underwent TEE for ischemic stroke of undetermined origin (2000 to 2003). Long-term survival was assessed using the Social Security Death Index. RESULTS: In a mean follow-up period of 3.0 (1.4 to 4.8) years, death occurred in 19.2% of patients. TEE findings included patent foramen ovale (18.8%), left atrium/left ventricle thrombus (2.4%), spontaneous echo contrast (3.7%), atrial septal aneurysm (3.3%), valve vegetation/mass/tumor (7.8%), complex aortic atheroma ([CAA]; 14.7%), and the composite of any cardiac source of embolus (39.2%). A total atherosclerotic burden (TAB) score was also recorded. On Cox hazard regression analysis, measures of aortic atherosclerosis (CAA [hazard ratio (HR), 2.7; 95% CI, 1.4 to 5.3] or TAB score [HR, 1.4; 95% CI, 1.2 to 1.6]) were independent predictors of death, whereas other TEE findings were not. CONCLUSIONS: In patients with ischemic stroke of undetermined origin referred for TEE, measures of aortic atherosclerosis, including CAA, represent the only TEE findings that predict long-term mortality after all other clinical factors are considered. Further study is needed to determine whether treatments for CAA effect long-term survival in patients with ischemic stroke.

Clinical features of complications from transesophageal echocardiography: a single-center case series of 10,000 consecutive examinations.

BACKGROUND: Transesophageal echocardiography (TEE) is an essential diagnostic tool that has gained widespread use in clinical cardiology. It is considered reasonably noninvasive and safe; however, insertion and operation of the TEE probe may cause hypopharyngeal, esophageal, or gastric trauma. The current study reports a single-center experience of esophagogastric trauma in 10,000 consecutive TEE examinations. METHODS: TEE examinations were performed by 9 attending physicians who were trained in endoscopic procedures and had been performing TEE studies for at least 1 year. RESULTS: One case of hypopharyngeal perforation (0.01%), 2 cases of cervical esophageal perforation (0.02%), and no cases of gastric perforation (0%) occurred after TEE examination. No fatalities (0%) occurred. We describe the clinical characteristics of individuals who experienced esophageal perforation during this 10-year period. CONCLUSIONS: This single-center study demonstrates that TEE examinations are associated with a very low risk of esophagogastric trauma when performed in a safe setting by experienced operators.

Feasibility of measuring coronary flow velocity and reserve in the left anterior descending coronary artery by transthoracic Doppler echocardiography in a relatively obese American population.

BACKGROUND: Transthoracic Doppler echocardiography (TTDE) assessment of coronary flow velocity reserve (CFVR) has been validated in Asian and European centers. This methodology has not gained acceptability in the United States due to the bias that coronary flow velocity (CFV) by TTDE might be difficult in an obese population with relatively poor acoustic windows. METHODS: Baseline CFV in the left anterior descending coronary artery (LAD) by TTDE was obtained in 67 nonselected American patients. A subset of 38/67 received adenosine infusion for measuring CFVR of the LAD. PURPOSE: The aim of this study was twofold: (1) to determine the feasibility of measuring CFV and CFVR in the LAD by TTDE in a relatively obese American population, and (2) to compare CFV and CFVR values in this population with those previously obtained in a group of Japanese patients. RESULTS: The mean body mass index (BMI) of the American population (28 +/- 6 kg/m2, range: 18-46 kg/m2) was significantly higher than that of the Japanese group (23 +/- 4 kg/m2, range: 15-37 kg/m2). Twenty-five American patients were classified as obese (BMI >30 kg/m2). Baseline CFV was obtained in 60/67 patients (feasibility: 90%) with a 10% need for intravenous contrast agent to enhance the delineation of the CFV envelope. The success rate in recording CFVR in American patients (92%) was nearly identical to that of a Japanese group (99%). The time-averaged peak diastolic coronary flow velocity increased from 15.6 +/- 5.5 cm/sec at baseline to 47.1 +/- 17.9 cm/sec during adenosine infusion, and CFVR was calculated to be 3.22 +/- 1.15 (range: 0.94-5.69). Intraobserver and interobserver variability for the CFV recording was 4.7 and 6.2%, respectively. CONCLUSIONS: These results suggest that the noninvasive measurement of CFV and CFVR of the LAD is feasible even in a relatively obese American population. Furthermore, the success rates for recording CFV and CFVR are similar to those measured in a Japanese population. This methodology has the potential to provide useful physiological information on the coronary circulation in American patients.

Racial differences in aortic atheroma in patients undergoing transesophageal echocardiography for unexplained stroke or transient ischemic attack.

Racial differences in the prevalence of complex thoracic aortic atheroma were evaluated in 318 patients referred for transesophageal echocardiography after unexplained stroke or transient ischemic attack. African-Americans were found to have fewer complex thoracic aortic atheroma and fewer combined cardiac sources of embolus than Caucasian patients. This finding persists after adjusting for racial differences in atherosclerotic risk factors.

Quantitative diagnosis of apical cardiomyopathy using contrast echocardiography.

BACKGROUND: The echocardiographic diagnosis of apical hypertrophic cardiomyopathy (ACM) has been limited by the frequent inability to visualize the apical endocardium. We hypothesized that the use of contrast agents in patients with suspected ACM, but nondiagnostic echocardiographic studies, would allow quantitative diagnosis. METHODS: Contrast enhancement was performed in 26 patients with nondiagnostic transthoracic echocardiograms (TTEs) for the diagnosis of ACM; 6 patients with suspected ACM based on unexplained symmetric precordial T-wave inversions and increased apical tracer uptake on single-photon emission computed tomography (SPECT) scans, 10 patients with normal electrocardiogram (ECG) readings and no history of hypertension (healthy group), and 10 patients with hypertension and ECG criteria for left ventricular hypertrophy (LVH group). Images were obtained with Optison (Mallinckrodt Medical; IV, 1.0 mL) using harmonic imaging and low mechanical index. Posterior (PW) and septal wall (SW) thicknesses were measured at end-diastole in the parasternal long-axis view. Apical wall thickness (A) was measured from the contrast-enhanced apical endocardium to the visceral epicardial surface in the apical 4-chamber view. A/PW and A/SW ratios were calculated for each group. Asymmetric apical hypertrophy was defined as an A/PW ratio greater than 1.5. RESULTS: Contrast-enhanced apical thickness was greater than 2.0 cm in all patients in the suspected ACM group but less than 1.2 cm in all patients in the LVH and healthy groups. In all 6 patients in the suspected ACM group, A/PW and A/SW ratios were greater than 1.5. No patient in the healthy or LVH groups had thickness ratios greater than 0.85. CONCLUSION: Contrast echocardiography allows quantitative diagnosis of ACM in patients with suggestive ECG and SPECT but nondiagnostic TTEs. This study suggests that contrast echocardiography should be performed before using more expensive or invasive diagnostic testing for this condition.